首页> 外文OA文献 >Tetrandrine, an activator of autophagy, induces autophagic cell death via PKC-α inhibition and mTOR-dependent mechanisms.
【2h】

Tetrandrine, an activator of autophagy, induces autophagic cell death via PKC-α inhibition and mTOR-dependent mechanisms.

机译:粉防己碱是一种自噬激活剂,通过pKC-α抑制和mTOR依赖性机制诱导自噬性细胞死亡。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Emerging evidence suggests the therapeutic role of autophagic modulators in cancer therapy. This study aims to identify novel traditional Chinese medicinal herbs as potential anti-tumor agents through autophagic induction, which finally lead to autophagy mediated-cell death in apoptosis-resistant cancer cells. Using bioactivity-guided purification, we identified tetrandrine (Tet) from herbal plant, Radix stephaniae tetrandrae, as an inducer of autophagy. Across a number of cancer cell lines, we found that breast cancer cells treated with tetrandrine show an increase autophagic flux and formation of autophagosomes. In addition, tetrandrine induces cell death in a panel of apoptosis-resistant cell lines that are deficient for caspase 3, caspase 7, caspase 3 and 7, or Bax-Bak respectively. We also showed that tetrandrine-induced cell death is independent of necrotic cell death. Mechanistically, tetrandrine induces autophagy that depends on mTOR inactivation. Furthermore, tetrandrine induces autophagy in a calcium/calmodulin-dependent protein kinase kinase-β (CaMKK-β), 5′ AMP-activated protein kinase (AMPK) independent manner. Finally, by kinase profiling against 300 WT kinases and computational molecular docking analysis, we showed that tetrandrine is a novel PKC-α inhibitor, which lead to autophagic induction through PKC-α inactivation. This study provides detailed insights into the novel cytotoxic mechanism of an anti-tumor compound originated from the herbal plant, which may be useful in promoting autophagy mediated- cell death in cancer cell that is resistant to apoptosis.
机译:新兴证据表明自噬调节剂在癌症治疗中的治疗作用。本研究旨在通过自噬诱导鉴定新型中药作为潜在的抗肿瘤药物,最终导致抗凋亡的癌细胞自噬介导的细胞死亡。使用生物活性指导的纯化,我们从草药中提取了粉防己碱(Tet),该药可以作为自噬的诱导剂。在许多癌细胞系中,我们发现用粉防己碱处理过的乳腺癌细胞显示出自噬通量增加和自噬体形成。此外,粉防己碱在一组分别缺乏胱天蛋白酶3,胱天蛋白酶7,胱天蛋白酶3和7或Bax-Bak的凋亡抗性细胞系中诱导细胞死亡。我们还表明粉防己碱诱导的细胞死亡与坏死细胞死亡无关。机械上,粉防己碱诱导依赖于mTOR失活的自噬。此外,粉防己碱以钙/钙调蛋白依赖性蛋白激酶激酶-β(CaMKK-β),5'AMP-活化蛋白激酶(AMPK)独立的方式诱导自噬。最后,通过针对300个WT激酶的激酶分析和分子对接计算,我们发现粉防己碱是一种新型的PKC-α抑制剂,可通过PKC-α失活导致自噬诱导。这项研究提供了对源自草药植物的抗肿瘤化合物的新型细胞毒性机制的详细见解,这可能有助于促进抗凋亡的癌细胞中自噬介导的细胞死亡。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号